First Horizon Corporation filed a Form 8-K on October 27, 2026, disclosing the election of Jeffrey R. Balser to its Board of Directors and the amendment of its Bylaws to expand the board from twelve to thirteen members, both effective October 26, 2026.

Key Highlights

  • New director elected: Jeffrey R. Balser was elected to the Boards of Directors of First Horizon Corporation and its subsidiary First Horizon Bank, effective October 26, 2026.
  • Balser's background: Dr. Balser, age 64, serves as President, CEO, and a board member of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine.
  • Committee assignments: Dr. Balser was appointed to the Nominating and Corporate Governance Committee and the Information Technology Committee of the Board.
  • Bylaws amended: Section 3.2 of First Horizon Corporation's Bylaws was amended to set the board size at thirteen members, increased from twelve.
  • Compensation eligibility: Dr. Balser will be eligible to participate in FHN's active compensation plans and programs for non-employee directors.
  • No selection arrangements: According to the filing, there are no arrangements or understandings between Dr. Balser and any other person concerning his selection to be elected to the Board.

First Horizon Adds Vanderbilt Medical Center Leader to Board, Expands Size to Thirteen

First Horizon Corporation (NYSE:FHN) reported on October 26, 2026 that it elected Jeffrey R. Balser to the Boards of Directors of both First Horizon Corporation and its subsidiary First Horizon Bank. The election was effective immediately, according to the filing. Dr. Balser is currently the President, Chief Executive Officer, and a member of the board of directors of Vanderbilt University Medical Center, an academic health system located in Nashville, Tennessee, and also serves as Dean of Vanderbilt University School of Medicine.

The filing describes Dr. Balser's background prior to his current role: before 2008, he served as chair of anesthesiology and later as chief research officer at Vanderbilt University Medical Center. He also practiced cardiac anesthesiology and cardiac intensive care medicine there and, before 1998, at Johns Hopkins, where he led a research program funded by the National Institutes of Health. The filing states that Dr. Balser has been appointed to two board committees: the Nominating and Corporate Governance Committee and the Information Technology Committee.

Concurrent with the director election, the Board unanimously approved an amendment to Section 3.2 of First Horizon Corporation's Bylaws, also effective October 26, 2026. As amended, that provision sets the number of Board of Directors members at thirteen, increased from twelve. The filing also noted that FHN and its subsidiaries have entered into lending and other banking or financial services transactions in the ordinary course of business with directors and other related parties, describing such transactions as made "on substantially the same terms, including interest rates and collateral, as those prevailing at the time for comparable transactions with persons not related to FHN."

What Was Disclosed

First Horizon Corporation disclosed the board election of Jeffrey R. Balser and an amendment to its Bylaws expanding board membership from twelve to thirteen, both effective October 26, 2026, via a Form 8-K filed October 27, 2026.